GO:1901662 quinone catabolic process: Quinone Breakdown, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901662 quinone catabolic process describes the chemical reactions and pathways that result in the breakdown of quinone molecules.
• Quinones are lipid-soluble electron carriers and enzyme cofactors, and their catabolism is essential for respiratory chain function and cellular redox balance.
• Key enzymes in quinone catabolism include quinone reductases, oxidoreductases, and glutathione-dependent detoxification systems.
• Dysregulated quinone catabolism contributes to oxidative stress, mitochondrial dysfunction, and diseases such as cancer and neurodegeneration.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes involved in quinone catabolic pathways.
• Understanding quinone catabolism supports drug discovery, metabolic engineering, and the development of cytoprotective quinone-based therapeutics.
Description
Quinones are a class of lipid-soluble organic molecules that function as electron carriers in respiratory and photosynthetic electron transport chains, as enzyme cofactors, and as signaling molecules. The controlled breakdown of quinones, defined by the Gene Ontology term GO:1901662 quinone catabolic process, is a critical metabolic process that prevents the accumulation of reactive quinone species and maintains cellular redox homeostasis. This process encompasses enzymatic and non-enzymatic reactions that convert quinones into smaller, often less reactive, metabolites. Researchers study quinone catabolic process because defects in quinone breakdown are linked to mitochondrial dysfunction, oxidative stress, and a range of human pathologies including cancer, neurodegeneration, and metabolic disorders. The process also intersects with glutathione metabolism, as glutathione conjugates and reduces quinones to protect cells from electrophilic stress. Understanding the molecular players and regulatory mechanisms of quinone catabolism is therefore essential for developing therapeutic strategies that target redox imbalance. Recent advances in mass spectrometry and isotope labeling have enabled the identification of quinone-quinone and quinone-catechol products, shedding light on the complexity of quinone catabolic pathways. Moreover, structural and biochemical studies of flavoprotein oxidoreductases have revealed diverse binding modes for quinones, informing drug design and enzyme engineering. This article provides a comprehensive overview of GO:1901662, covering its definition, biological significance, key genes, disease associations, and experimental models for research.
quinone catabolic process At A Glance
| GO ID | GO:1901662 |
|---|---|
| GO term | quinone catabolic process |
| Ontology | biological_process |
| Synonym | quinone breakdown; quinone catabolism; quinone cofactor breakdown; quinone cofactor catabolic process; quinone cofactor catabolism; quinone cofactor degradation; quinone degradation |
| Major function | Breakdown of quinone molecules to maintain redox balance and prevent toxicity |
| Related processes | Electron transport chain, glutathione metabolism, oxidative stress response |
| Key enzymes | Quinone reductases, flavoprotein oxidoreductases, glutathione S-transferases |
| Cellular location | Mitochondria, cytoplasm, and membrane-associated compartments |
What Is GO:1901662?
The quinone catabolic process (GO:1901662) is defined as the chemical reactions and pathways resulting in the breakdown of quinone molecules. This includes the enzymatic conversion of quinones into catabolic intermediates and end products, as well as spontaneous degradation reactions. The process is essential for maintaining quinone homeostasis and preventing the toxic accumulation of reactive quinone species.
Why Is quinone catabolic process Important in Cell Biology?
Quinone catabolic process is vital for cellular health because quinones can undergo redox cycling to generate reactive oxygen species (ROS) and cause oxidative damage to proteins, lipids, and DNA. By breaking down quinones, cells mitigate these toxic effects and recycle cofactors for respiratory chain function. Dysregulation of quinone catabolism has been implicated in mitochondrial diseases, cancer, and neurodegenerative disorders, making it a promising target for therapeutic intervention.
• Maintains mitochondrial electron transport chain efficiency by preventing quinone accumulation.
• Protects cells from oxidative stress and electrophilic damage caused by reactive quinones.
• Interfaces with glutathione metabolism to detoxify quinone species.
• Influences cellular signaling pathways through redox-sensitive transcription factors.
• Plays a role in drug metabolism and detoxification of xenobiotics.
• Contributes to the catabolism of quinone cofactors such as ubiquinone and menaquinone.
• Dysregulation is linked to cancer, neurodegeneration, and metabolic disorders.
• Provides targets for the development of cytoprotective short-chain quinones.
• Enables metabolic engineering of quinone-dependent pathways in biotechnology.
• Serves as a model for studying enzyme mechanisms and substrate specificity.
What Happens During quinone catabolic process?
Initial Reduction and Activation
In simple terms: Quinones are first chemically modified to become more reactive or easier to break down.
The catabolism of quinones often begins with reduction by quinone reductases, such as NAD(P)H:quinone oxidoreductase 1 (NQO1), which converts quinones to hydroquinones. This step can be enzymatic or non-enzymatic and may involve one- or two-electron transfer mechanisms. The resulting hydroquinones are more susceptible to further degradation or conjugation.
Conjugation and Ring Cleavage
In simple terms: The modified quinone is linked to other molecules and its ring structure is opened.
Hydroquinones can undergo conjugation with glutathione, sulfate, or glucuronic acid, facilitating their excretion or further metabolism. Ring cleavage may occur through dioxygenase or monooxygenase activities, producing smaller metabolites such as muconic acid derivatives. Isotope labeling studies have identified quinone-quinone and quinone-catechol products, indicating complex coupling reactions during catabolism.
Oxidative Degradation and Product Formation
In simple terms: The breakdown products are further oxidized and converted into final waste molecules.
Oxidative degradation of quinone catabolites can generate reactive intermediates, including semiquinones and ROS, which are detoxified by cellular antioxidant systems. The final products often include carboxylic acids, carbon dioxide, and water, which are excreted or reused in metabolism. The balance between detoxification and ROS generation is critical for cell survival.
Integration with Respiratory Chain
In simple terms: Quinone breakdown is connected to the energy-producing machinery of the cell.
Quinone catabolism intersects with the respiratory chain because quinones are essential electron carriers in complexes I, II, and III. The breakdown of damaged or excess quinones ensures that the respiratory chain is not overwhelmed by non-functional quinone species. This integration is vital for maintaining ATP production and mitochondrial membrane potential.
Key Genes Involved in GO:1901662 quinone catabolic process
The following genes and proteins are key players in quinone catabolic process, based on their enzymatic activities and roles in quinone metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NQO1 | NAD(P)H:quinone oxidoreductase 1; reduces quinones to hydroquinones | Protects against oxidative stress; target for cancer chemoprevention |
| NQO2 | Quinone reductase 2; catalyzes two-electron reduction of quinones | Involved in detoxification and drug metabolism |
| GSTs | Glutathione S-transferases; conjugate glutathione to quinones | Detoxify electrophilic quinones; linked to cancer resistance |
| COQ genes | Coenzyme Q (ubiquinone) biosynthesis and catabolism | Mitochondrial function; mutations cause CoQ deficiency |
| CYP450 | Cytochrome P450 enzymes; oxidize quinones | Drug metabolism and quinone activation |
| NQO1 | Quinone reductase; also acts as a chaperone | Role in proteasome regulation and cancer |
| AKR | Aldo-keto reductases; reduce quinones | Detoxification and metabolic regulation |
| FAD-dependent oxidoreductases | Flavoprotein oxidoreductases; bind quinones | Structural studies inform inhibitor design |
| Glutathione peroxidase | Reduces hydrogen peroxide and lipid peroxides | Protects against quinone-induced oxidative stress |
| Superoxide dismutase | Converts superoxide to hydrogen peroxide | Mitigates ROS from quinone redox cycling |
| Catalase | Decomposes hydrogen peroxide | Defense against quinone-generated ROS |
| Thioredoxin | Redox regulator; reduces disulfides | Maintains redox balance during quinone catabolism |
| Nrf2 | Transcription factor; regulates antioxidant response | Induces NQO1 and GSTs in response to quinones |
| Bcl-2 | Anti-apoptotic protein; modulates ROS | Influences cell survival during quinone stress |
| p53 | Tumor suppressor; responds to oxidative DNA damage | Mutated in cancers with quinone exposure |
| PARP | DNA repair enzyme; activated by oxidative damage | Involved in quinone-induced DNA damage response |
| SIRT1 | NAD+-dependent deacetylase; regulates stress response | Modulates quinone catabolism and aging |
| AMPK | Energy sensor; regulates mitochondrial function | Links quinone catabolism to metabolic stress |
How Is quinone catabolic process Regulated?
Quinone catabolic process is regulated at multiple levels, including transcriptional activation of antioxidant response elements by Nrf2, which induces NQO1 and glutathione S-transferases. Post-translational modifications, such as phosphorylation by AMPK, can modulate the activity of quinone reductases and mitochondrial function. Additionally, the availability of NAD(P)H and glutathione, as well as the redox state of the cell, influences the flux through quinone catabolic pathways. Dysregulation of these regulatory mechanisms can lead to quinone accumulation and oxidative stress.
quinone catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NQO1 | Cancer chemoresistance; oxidative stress | NQO1 knockout cancer cell lines; overexpression models |
| COQ2 | Coenzyme Q10 deficiency; mitochondrial disease | Patient-derived fibroblasts; COQ2 knockout mice |
| GSTP1 | Cancer susceptibility; drug detoxification | GSTP1 knockout and knock-in cell lines |
| Nrf2 | Chronic obstructive pulmonary disease; cancer | Nrf2 knockout mice; reporter cell lines |
| p53 | Li-Fraumeni syndrome; cancer | p53 knockout and point-mutant cell lines |
Cancer
Altered quinone catabolism is observed in many cancers, where overexpression of NQO1 and GSTs contributes to chemoresistance and enhanced survival under oxidative stress. Quinone-induced DNA damage and mutations in p53 are linked to carcinogenesis. Targeting quinone catabolic enzymes is a strategy for sensitizing cancer cells to chemotherapy.
Neurodegeneration
In neurodegenerative diseases such as Parkinson's and Alzheimer's, impaired quinone catabolism leads to mitochondrial dysfunction and ROS accumulation, contributing to neuronal death. Coenzyme Q10 deficiency, caused by mutations in COQ genes, results in severe neurological phenotypes.
Mitochondrial Disorders
Defects in quinone catabolism and respiratory chain complexes are associated with mitochondrial myopathies and encephalopathies. Mutations in genes involved in ubiquinone biosynthesis or catabolism cause primary CoQ10 deficiency, a rare but treatable condition.
Metabolic Syndrome
Dysregulated quinone metabolism contributes to insulin resistance and obesity-related oxidative stress. Short-chain quinones with cytoprotective activity are being explored as therapeutics for metabolic disorders.
From quinone catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NQO1 increase sensitivity to quinone-induced toxicity? | NQO1 knockout cell lines (e.g., HeLa, A549) |
| How do point mutations in COQ2 affect ubiquinone catabolism? | COQ2 point-mutation knock-in cells |
| Can overexpression of GSTs protect against quinone electrophiles? | GST-overexpressing stable cell lines |
| What is the role of Nrf2 in regulating quinone catabolic genes? | Nrf2 knockout and knock-in reporter models |
| Does a tagged NQO1 variant localize differently under oxidative stress? | NQO1-GFP knock-in cells |
| Can CRISPR library screening identify novel regulators of quinone catabolism? | Genome-wide CRISPR knockout library in quinone-sensitive cells |
How to Study the quinone catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| UPLC-Q-TOF/MS | Mass and fragmentation of quinone metabolites | Identification of catabolic products |
| 13C labeling | Isotopic enrichment in metabolites | Tracing quinone catabolic pathways |
| Quinone reductase assay | Enzymatic reduction of quinones | Measuring NQO1 activity |
| GST activity assay | Glutathione conjugation rate | Detoxification capacity |
| CRISPR knockout screen | Gene essentiality and sensitivity | Discovery of quinone catabolism regulators |
| roGFP imaging | Cellular redox potential | Real-time oxidative stress monitoring |
| Western blot | Protein expression levels | Validation of knockout/overexpression |
| RNA-seq | Transcriptional changes | Pathway analysis under quinone stress |
Mass Spectrometry and Isotope Labeling
UPLC-Q-TOF/MS and UPLC-Q-Exactive Orbitrap/MS with 13C labeling enable the identification and quantification of quinone catabolic products, including quinone-quinone and quinone-catechol adducts. These methods are essential for mapping catabolic pathways and detecting novel metabolites.
Enzyme Activity Assays
Quinone reductase activity can be measured spectrophotometrically by monitoring the reduction of substrates such as dichlorophenolindophenol (DCPIP) or cytochrome c. Glutathione conjugation assays assess GST activity toward quinones.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to quinones, revealing novel regulators of quinone catabolism. Bioinformatics analysis of screening data prioritizes candidate genes for validation.
Imaging and Redox Sensors
Genetically encoded redox sensors (e.g., roGFP) and fluorescent probes can monitor real-time changes in cellular redox state during quinone catabolism. Live-cell imaging of tagged enzymes (e.g., NQO1-GFP) reveals subcellular localization dynamics.
How CRISPR Can Be Used to Study GO:1901662 quinone catabolic process
Knockout
CRISPR knockout of genes such as NQO1, GSTs, or COQ2 allows researchers to assess their necessity in quinone catabolism and cellular resistance to quinone toxicity. Knockout cell lines can be used in drug sensitivity assays and metabolic profiling.
Point Mutation
Introducing point mutations (e.g., in NQO1 or COQ2) via CRISPR base editing or homology-directed repair enables the study of specific amino acid residues in enzyme catalysis and substrate binding. This is valuable for understanding genetic variants associated with disease.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of quinone catabolic enzymes facilitates localization, interaction, and real-time activity studies. Knock-in of disease-associated mutations creates isogenic models for mechanistic research.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like NQO1 or GSTs can test their protective effects against quinone-induced oxidative stress and identify downstream pathways. Overexpression models are useful for drug screening.
How EDITGENE Supports quinone catabolic process Research
Researchers studying quinone catabolic process-related genes often need to determine whether a candidate gene is causally involved in quinone detoxification, mitochondrial function, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for quinone catabolic process research.
Frequently Asked Questions About quinone catabolic process
What is quinone catabolic process?
Quinone catabolic process (GO:1901662) is the set of chemical reactions and pathways that break down quinone molecules, preventing their toxic accumulation and maintaining cellular redox balance.
What genes are involved in quinone catabolic process?
Key genes include NQO1, NQO2, GSTs, COQ genes, and various cytochrome P450 and aldo-keto reductases that metabolize quinones.
Why is quinone catabolism important for health?
It protects cells from oxidative stress and mitochondrial dysfunction caused by reactive quinones, and its dysregulation is linked to cancer, neurodegeneration, and metabolic disorders.
How is quinone catabolic process regulated?
It is regulated by Nrf2-mediated antioxidant response, AMPK signaling, and the availability of NAD(P)H and glutathione.
What diseases are associated with defective quinone catabolism?
Defective quinone catabolism is associated with cancer, neurodegenerative diseases, mitochondrial disorders, and metabolic syndrome.
What methods are used to study quinone catabolic process?
Methods include mass spectrometry with isotope labeling, enzyme activity assays, CRISPR screening, and redox imaging.
Can CRISPR be used to study quinone catabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of genes involved in quinone catabolism.
What is the role of NQO1 in quinone catabolism?
NQO1 reduces quinones to hydroquinones, preventing redox cycling and oxidative stress, and is a target for cancer chemoprevention.
How does glutathione metabolism interact with quinone catabolism?
Glutathione conjugates and reduces quinones, facilitating their detoxification and excretion, and is essential for cellular defense against quinone electrophiles.
What are the research models for quinone catabolic process?
Common models include knockout cell lines, point-mutation knock-ins, tagged knock-ins, overexpression systems, and genome-wide CRISPR screens.
Conclusion
Quinone catabolic process (GO:1901662) is a fundamental biological pathway that safeguards cells against the toxic effects of quinones and supports mitochondrial function. Its dysregulation is implicated in a wide range of diseases, making it a compelling area for therapeutic development. Advances in CRISPR technology and analytical methods continue to unravel the molecular details of quinone catabolism, offering new opportunities for drug discovery and precision medicine. By leveraging EDITGENE's comprehensive CRISPR services, researchers can dissect the roles of individual genes in quinone catabolism, identify novel drug targets, and translate these findings into clinical applications.
References
- 1. McIntire WS. 1994. Quinoproteins.. FASEB J 8(8):513-21 PMID: 8181669
- 2. Marreiros BC et al.. 2016. Exploring membrane respiratory chains.. Biochim Biophys Acta 1857(8):1039-1067 PMID: 27044012
- 3. Watanabe N et al.. 2004. Quinones and glutathione metabolism.. Methods Enzymol 378:319-40 PMID: 15038978
- 4. O'Brien PJ. 1991. Molecular mechanisms of quinone cytotoxicity.. Chem Biol Interact 80(1):1-41 PMID: 1913977
- 5. Lenaz G et al.. 2004. Mitochondrial quinone reductases: complex I.. Methods Enzymol 382:3-20 PMID: 15047093
- 6. Alt TB et al.. 2025. The binding modes of quinones in flavoprotein oxidoreductases.. Arch Biochem Biophys 770:110443 PMID: 40320059
- 7. Geng Y et al.. 2023. Investigation of the Quinone-quinone and Quinone-catechol products using (13)C labeling, UPLC-Q-TOF/MS and UPLC-Q-Exactive Orbitrap/MS.. Food Res Int 164:112397 PMID: 36737980
- 8. Feng Z et al.. 2021. Bioactivity Profiles of Cytoprotective Short-Chain Quinones.. Molecules 26(5) PMID: 33806577
